Radiation Exposure Concerns Addressed in Survey of Interventional Specialists 

November 19, 2025—Gore & Associates and Egg Medical announced findings from a national poll on the concerns regarding radiation exposure in operating rooms and catheterization labs across the country.

According to the companies, the double-blinded online survey was conducted on November 4-5, 2025. A total of 72 United States physicians participated in the survey, answering questions about their radiation exposure in their day-to-day work. The physicians represented various specialties, including vascular surgeons, interventional radiologists, cardiac surgeons, and interventional cardiologists.

As outlined in the press release, the findings from the poll revealed the following:

• 100% of interventional cardiologists, 96% of interventional radiologists, 93% of vascular surgeons, and 71% of cardiac surgeons are concerned about their radiation exposure when performing image-guided procedures
• Although approximately 80% of vascular surgeons said they are “extremely or very concerned” about radiation exposure, only 27% reported using an enhanced or advanced radiation protection device or wearing live dosimetry, and only 13% reported wearing double lead
• 64% of interventional radiologists and interventional cardiologists said they use an enhanced or advanced radiation protection device
• 60% of interventional cardiologists reported wearing live dosimetry compared to 36% of interventional radiologists
• Approximately 40% of interventional cardiologists reported wearing double lead compared to 12% of interventional radiologists
• 44% of interventional radiologists reported limiting radiation exposure by performing fewer procedures
• Less than 30% of all respondents reported feeling “very protected” from radiation exposure

At the 2025 VEITHsymposium, the companies demonstrated the need for radiation protection through a simulation experience, noted the press release. The companies further stated that they are collaborating to increase access and expand deployment of radiation protection solutions, leveraging Gore’s extensive clinical reach and Egg Medical’s expertise in radiation safety innovation.

“These results highlight an urgent need to better protect those who make patient care possible,” commented Jason Belzer, Americas Commercial Leader for Gore’s medical business, in the press release. “Partnering with Egg Medical allows Gore to bring greater visibility and practical solutions to reduce radiation risk—reinforcing our shared commitment to keeping everyone safe in the operating room and the cath lab.”

Gavin Philipps, Chief Commercial Officer for Egg Medical, added, “[These] data confirm what we’ve long understood—interventional physicians are deeply concerned about their radiation exposure and the limitations of traditional protection. We’re proud to provide a solution with the EggNest system that delivers the comprehensive protection they’ve been asking for, and through our partnership with Gore, we’re excited to bring this technology to more clinicians and hospitals even faster.”